Zydus Wellness quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	1,437	861	+66.9%
EBITDA	242	156	+55.3%
EBITDA margin	16.8%	18.1%	−1.2 pts
Profit before tax	162	145	+11.6%
Net profit	119	128	−7.0%
EPS	₹3.74	₹20.10	−81.4%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	1,437	1,485	965	651	861	913	462	493	841	783	403	440	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	3.8	1.2	0.8	1.4	3.0	0.8	3.8	4.0	5.0	4.0	3.4	4.1
	1,441	1,486	966	652	864	914	466	497	846	787	407	444
	308	384	300	261	267	434	286	207	258	351	233	182
	143	192	129	43.6	51.2	68.5	7.4	13.3	54.8	51.7	11.2	13.7
	43.2	−57.0	−76.4	2.2	69.4	−90.6	−58.1	37.4	60.9	−47.8	−34.7	46.0
	96.8	105	73.8	66.4	68.2	73.3	52.3	52.2	59.4	53.6	44.2	48.3
	26.3	38.7	41.2	15.7	2.5	4.2	3.3	0.9	3.6	6.1	6.3	6.5
	57.1	55.3	55.5	25.1	10.8	13.2	5.2	4.9	5.1	5.7	6.1	5.8
	605	590	477	255	249	238	159	164	253	212	137	134
	1,279	1,309	1,001	668	719	741	456	479	694	632	403	435
	242	270	61.0	23.0	156	190	14.8	19.6	155	162	12.7	16.8
	185	215	5.5	−2.1	145	177	9.6	14.7	150	157	6.6	11.0
Profit
	162	177	−34.9	−16.4	145	173	10.1	17.8	152	154	3.7	8.6
	0.0	0.0	−6.6	−34.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
	162	177	−41.5	−50.6	145	173	10.1	23.7	152	154	3.7	8.6
	40.1	11.7	9.2	8.9	0.8	−0.1	0.2	0.0	0.1	0.1	0.3	0.0
	3.1	3.6	−10.8	−6.7	16.6	1.6	3.5	2.8	3.8	4.0	3.1	2.7
	43.2	15.3	−1.6	2.2	17.4	1.5	3.7	2.8	3.9	4.1	3.4	2.7
	119	162	−39.9	−52.8	128	172	6.4	20.9	148	150	0.3	5.9
	119	162	−39.9	−52.8	128	172	6.4	20.9	148	150	0.3	5.9
	−11.0	−2.2	−1.2	−1.2	0.0	−0.6	−0.4	0.1	−0.1	0.1	−0.1	−0.1
	108	160	−41.1	−54.0	128	171	6.0	21.0	148	150	0.2	5.8
	119	162	−39.9	−52.8	128	172	6.4	20.9	148	150	0.3	5.9
Per share
	₹3.74	₹5.09	−₹1.25	−₹1.66	₹20.10	₹27.01	₹1.01	₹3.28	₹23.21	₹23.62	₹0.05	₹0.93
	₹3.74	₹5.09	−₹1.25	−₹1.66	₹20.10	₹27.01	₹1.01	₹3.28	₹23.21	₹23.62	₹0.05	₹0.93
Other comprehensive income — detail
	−11.0	−2.2	−1.2	−1.2	0.0	−0.6	—	—	—	—	—	—
	—	0.1	0.0	−0.4	−0.2	−1.0	0.2	0.1	0.1	0.2	−0.1	0.0
	0.0	0.0	0.0	−0.1	0.0	−0.2	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	0.1	0.0	0.0	0.0
	−11.0	−2.3	−1.2	−0.9	0.2	0.2	−0.6	0.0	−0.1	−0.1	0.0	−0.1
	—	—	—	—	128	−0.6	−0.4	21.0	148	150	0.2	5.8
	—	—	—	—	0.0	171	6.0	0.0	0.0	0.0	0.0	0.0
Per share — as-filed variants
	₹3.74	₹5.09	−₹1.25	−₹1.66	₹20.10	₹27.01	₹1.01	₹3.28	₹23.21	₹23.62	₹0.05	₹0.93
	₹3.74	₹5.09	−₹1.25	−₹1.66	₹20.10	₹27.01	₹1.01	₹3.28	₹23.21	₹23.62	₹0.05	₹0.93
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	944	965	612	344	473	501	226	235	468	428	194	199
	65.7%	65.0%	63.4%	52.9%	55.0%	54.9%	49.0%	47.8%	55.6%	54.6%	48.1%	45.2%
Adjusted (ex-exceptional items) — derived
	162	177	−34.9	−16.4	145	173	10.1	17.8	152	154	3.7	8.6
	0.0	0.0	−6.6	−34.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
	119	162	−33.6	−18.6	128	172	6.4	15.7	148	150	0.3	5.9
	₹3.74	₹5.09	−₹1.05	−₹0.58	₹20.10	₹27.01	₹1.01	₹2.46	₹23.21	₹23.62	₹0.05	₹0.93

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ZYDUSWELL₹463.60

Zydus Wellness Ltd.

· FMCG & Retail

Annual Quarterly₹ CrorePeersDABUR EMAMILTD TATACONSUM LTFOODS HONASA GILLETTE EIDPARRY DOMSMcap ₹14,742 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	439.9	403.2	782.6	841.0	492.9	461.9	913.1	860.9	650.5	964.9	1,484.7	1,437.0
Other Income	4.1	3.4	4.0	5.0	4.0	3.8	0.8	3.0	1.4	0.8	1.2	3.8
Total Income	444.0	406.6	786.6	846.0	496.9	465.7	913.9	863.9	651.9	965.7	1,485.9	1,440.8
Expenses
+ Cost of Materials Consumed	181.5	232.7	351.1	257.6	206.8	286.3	433.8	267.2	260.5	300.2	384.4	307.6
+ Purchases of Stock-in-Trade	13.7	11.2	51.7	54.8	13.3	7.4	68.5	51.2	43.6	129.3	192.3	142.6
+ Changes in Inventories	46.0	-34.7	-47.8	60.9	37.4	-58.1	-90.6	69.4	2.2	-76.4	-57.0	43.2
+ Employee Benefit Expense	48.3	44.2	53.6	59.4	52.2	52.3	73.3	68.2	66.4	73.8	104.6	96.8
+ Finance Costs	6.5	6.3	6.1	3.6	0.9	3.3	4.2	2.5	15.7	41.2	38.7	26.3
+ Depreciation & Amortisation	5.8	6.1	5.7	5.1	4.9	5.2	13.2	10.8	25.1	55.5	55.3	57.1
+ Other Expenses	133.6	137.1	211.8	253.0	163.6	159.2	238.1	249.3	254.8	477.0	590.3	605.1
Total Expenses	435.4	402.9	632.2	694.4	479.1	455.6	740.5	718.6	668.3	1,000.6	1,308.6	1,278.7
EBITDA	16.8	12.7	162.2	155.3	19.6	14.8	190.0	155.6	23.0	61.0	270.1	241.7
EBIT	11.0	6.6	156.5	150.2	14.7	9.6	176.8	144.8	-2.1	5.5	214.8	184.6
Profit
PBT before Exceptional Items	8.6	3.7	154.4	151.6	17.8	10.1	173.4	145.3	-16.4	-34.9	177.3	162.1
+ Exceptional Items	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	-34.2	-6.6	0.0	0.0
Pretax Income	8.6	3.7	154.4	151.6	23.7	10.1	173.4	145.3	-50.6	-41.5	177.3	162.1
+ Current Tax	0.0	0.3	0.1	0.1	0.0	0.2	-0.1	0.8	8.9	9.2	11.7	40.1
+ Deferred Tax	2.7	3.1	4.0	3.8	2.8	3.5	1.6	16.6	-6.7	-10.8	3.6	3.1
Tax Expense	2.7	3.4	4.1	3.9	2.8	3.7	1.5	17.4	2.2	-1.6	15.3	43.2
Net Income	5.9	0.3	150.3	147.7	20.9	6.4	171.9	127.9	-52.8	-39.9	162.0	118.9
+ Net Income — Continuing Ops	5.9	0.3	150.3	147.7	20.9	6.4	171.9	127.9	-52.8	-39.9	162.0	118.9
+ Other Comprehensive Income	-0.1	-0.1	0.1	-0.1	0.1	-0.4	-0.6	0.0	-1.2	-1.2	-2.2	-11.0
Total Comprehensive Income	5.8	0.2	150.4	147.6	21.0	6.0	171.3	127.9	-54.0	-41.1	159.8	107.9
Net Income to Common	5.9	0.3	150.3	147.7	20.9	6.4	171.9	127.9	-52.8	-39.9	162.0	118.9
Per Share
Basic EPS	0.93	0.05	23.62	23.21	3.28	1.01	27.01	20.10	-1.66	-1.25	5.09	3.74
Diluted EPS	0.93	0.05	23.62	23.21	3.28	1.01	27.01	20.10	-1.66	-1.25	5.09	3.74
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-0.6	0.0	-1.2	-1.2	-2.2	-11.0
+ Items NOT to be Reclassified to P&L	0.0	-0.1	0.2	0.1	0.1	0.2	-1.0	-0.2	-0.4	0.0	0.1	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.2	0.0	-0.1	0.0	0.0	0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	0.0	0.1	0.0	0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-0.1	0.0	-0.1	-0.1	0.0	-0.6	0.2	0.2	-0.9	-1.2	-2.3	-11.0
Comprehensive Income — Owners of Parent	5.8	0.2	150.4	147.6	21.0	-0.4	-0.6	127.9	—	—	—	—
Comprehensive Income — Non-controlling Interests	0.0	0.0	0.0	0.0	0.0	6.0	171.3	0.0	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.93	0.05	23.62	23.21	3.28	1.01	27.01	20.10	-1.66	-1.25	5.09	3.74
Diluted EPS — Continuing Operations	0.93	0.05	23.62	23.21	3.28	1.01	27.01	20.10	-1.66	-1.25	5.09	3.74
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	198.7	194.0	427.6	467.7	235.4	226.3	501.4	473.1	344.2	611.8	965.0	943.6
Gross Margin %	45.17	48.12	54.64	55.61	47.76	48.99	54.91	54.95	52.91	63.41	65.00	65.66
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	8.6	3.7	154.4	151.6	17.8	10.1	173.4	145.3	-16.4	-34.9	177.3	162.1
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	-34.2	-6.6	0.0	0.0
Net Income Adj (tax-effected)	5.9	0.3	150.3	147.7	15.7	6.4	171.9	127.9	-18.6	-33.6	162.0	118.9
EPS Adj	0.93	0.05	23.62	23.21	2.46	1.01	27.01	20.10	-0.58	-1.05	5.09	3.74
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	63.6	63.6	63.6	63.6	63.6	63.6	63.6	63.6	63.6	63.6	63.6	63.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Zydus Wellness Q2 FY27 results date

Zydus Wellness (NSE: ZYDUSWELL) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 15 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹119 crore, down 7.0% from ₹128 crore in Q1 FY26 and down 26.6% from ₹162 crore in Q4 FY26. Revenue from operations was ₹1,437 crore, up 66.9% year on year and down 3.2% from the previous quarter.

Board-meeting notice filed: 15 October 2026
Q2 FY26 results (a year earlier): 5 November 2025
Q1 FY27 results (the latest): 4 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 15 Oct
Q1 FY27 net profit: ₹119 Cr−7.0% vs Q1 FY26−26.6% vs Q4 FY26
Q1 FY27 revenue: ₹1,437 Cr+66.9% vs Q1 FY26−3.2% vs Q4 FY26
Q1 FY27 operating margin: 12.8%−4.0 pts vs Q1 FY26−1.6 pts vs Q4 FY26
Q2 FY26 net loss (a year earlier): −₹52.8 CrRevenue ₹651 Cr
Q1 FY27 EPS (basic): ₹3.74

Questions

When will Zydus Wellness announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 15 October 2026). Last year it reported Q2 FY26 on 5 November 2025.

What will Zydus Wellness' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net loss was ₹52.8 crore and revenue from operations ₹651 crore. The latest quarter, Q1 FY27, had a net profit of ₹119 crore and revenue of ₹1,437 crore.

What were Zydus Wellness' Q1 FY27 results?

Consolidated net profit was ₹119 crore, down 7.0% from ₹128 crore in Q1 FY26 and down 26.6% from ₹162 crore in Q4 FY26. Revenue from operations was ₹1,437 crore, up 66.9% year on year and down 3.2% from the previous quarter.

How has Zydus Wellness' profit changed over the last four quarters?

Net profit by quarter: a loss of ₹52.8 crore in Q2 FY26, a loss of ₹39.9 crore in Q3 FY26, a profit of ₹162 crore in Q4 FY26 and a profit of ₹119 crore in Q1 FY27. That is a combined profit of ₹188 crore over the four quarters, down 42.5% from ₹327 crore in the four quarters before. Revenue from operations: ₹651 crore, ₹965 crore, ₹1,485 crore and ₹1,437 crore.

What was Zydus Wellness' net profit in FY26?

Consolidated net profit was ₹197 crore in FY26 (April 2025–March 2026), down 43.2% from ₹347 crore in FY25. It was ₹267 crore in FY24 and ₹310 crore in FY23: down 36.5% over three years, an average fall of 14.0% a year.

What was Zydus Wellness' revenue in FY26?

Revenue from operations was ₹3,961 crore in FY26 (April 2025–March 2026), up 46.2% from ₹2,709 crore in FY25. It was ₹2,328 crore in FY24 and ₹2,255 crore in FY23: up 75.7% over three years, 20.7% a year on average.

Where do these Zydus Wellness figures come from?

From Zydus Wellness' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.